Aspirin tolerance following omalizumab therapy in a patient with aspirin-exacerbated respiratory disease

被引：16
|
作者：
Aksu, K. [1 ]
Kurt, E. [1 ]
机构：
[1] Eskisehir Osmangazi Univ, Fac Med, Dept Chest Dis, Div Immunol & Allergy, TR-26480 Eskisehir, Turkey
来源：
ALLERGOLOGIA ET IMMUNOPATHOLOGIA | 2013年 / 41卷 / 03期
关键词：
ASTHMATICS;
D O I：
10.1016/j.aller.2012.02.005
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：208 / 210
页数：3
相关论文
共 50 条
  • [21] Biomarkers for predicting response to aspirin therapy in aspirin-exacerbated respiratory disease
    Tyrak, Katarzyna E.
    Pajdzik, Kinga
    Jakiela, Bogdan
    Kuprys-Lipinska, Izabela
    Cmiel, Adam
    Kacorzyk, Radoslaw
    Trad, Gabriela
    Kuna, Piotr
    Sanak, Marek
    Mastalerz, Lucyna
    CLINICAL AND EXPERIMENTAL ALLERGY, 2021, 51 (08): : 1046 - 1056
  • [22] Omalizumab ameliorates extrarespiratory symptoms in patients with aspirin-exacerbated respiratory disease
    Hayashi, Hiroaki
    Fukutomi, Yuma
    Mitsui, Chihiro
    Kajiwara, Keiichi
    Watai, Kentaro
    Tomita, Yasuhiro
    Kamide, Yosuke
    Tsuburai, Takahiro
    Sekiya, Kiyoshi
    Ishii, Makoto
    Hasegawa, Yoshinori
    Taniguchi, Masami
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (06) : 1667 - +
  • [23] Omalizumab: A Potential New Therapeutic Approach for Aspirin-Exacerbated Respiratory Disease
    Bobolea, I.
    Barranco, P.
    Fiandor, A.
    Cabanas, R.
    Quirce, S.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2010, 20 (05) : 448 - 449
  • [24] Performing Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease
    Waldram, Jeremy D.
    Simon, Ronald A.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2016, 36 (04) : 693 - +
  • [25] Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease A Randomized Controlled Trial
    Hayashi, Hiroaki
    Fukutomi, Yuma
    Mitsui, Chihiro
    Kajiwara, Keiichi
    Watai, Kentaro
    Kamide, Yosuke
    Nakamura, Yuto
    Hamada, Yuto
    Tomita, Yasuhiro
    Sekiya, Kiyoshi
    Tsuburai, Takahiro
    Izuhara, Kenji
    Wakahara, Keiko
    Hashimoto, Naozumi
    Hasegawa, Yoshinori
    Taniguchi, Masami
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201 (12) : 1488 - 1498
  • [26] Aspirin-exacerbated respiratory disease: aspirin desensitisation treatment
    Geraldo Dias, J.
    Costa, A.
    Caiado, J.
    Pedro, E.
    Pereira Barbosa, M.
    ALLERGY, 2010, 65 : 603 - 604
  • [27] Dysbiosis in aspirin-exacerbated respiratory disease
    Cook, Kevin A.
    Domissy, Alain
    Simon, Ronald A.
    White, Andrew A.
    Modena, Brian D.
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2021, 11 (07) : 1116 - 1120
  • [28] Aspirin-exacerbated Respiratory Disease (AERD)
    Klimek, Ludger
    ALLERGOLOGIE, 2014, 37 (01) : 2 - 3
  • [29] Aspirin-Exacerbated Respiratory Disease REPLY
    White, Andrew A.
    Stevenson, Donald D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (23): : 2281 - 2282
  • [30] Pathogenesis of aspirin-exacerbated respiratory disease
    Donald D. Stevenson
    Bruce L. Zuraw
    Clinical Reviews in Allergy & Immunology, 2003, 24 : 169 - 187
12345